AstraZeneca’s BAXFENDY™ (baxdrostat) has been approved in the US as a first-in-class aldosterone synthase inhibitor (ASI) for the treatment of hypertension in combination with other antihypertensive ...

A new blood pressure medication has been approved in the U.S., but this one isn't quite like others that help treat hypertension. Baxfendy, from pharmaceutical maker AstraZeneca, is the "first and ...

A meta-analysis involving more than 43,000 adults with obesity, suggests that obesity medications, such as GLP-1 drugs, could ...

Pulmonary Arterial Hypertension Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight The pulmonary arterial hypertension clinical trial ...

The pharmaceutical company expects the drug Baxfendy to generate multibillion-dollar annual sales at its peak.

Baxfendy inhibits a blood-pressure-raising enzyme and, according to AstraZeneca executives, is poised to be a “big product” ...

Researchers at Penn State created a soft implant called CaroFlex that may help lower high blood pressure without extra medicines.

The FDA has approved AstraZeneca's aldosterone synthase inhibitor (ASI) – baxdrostat – for hard-to-treat hypertension, making ...

The Punjab government on World Hypertension Day said its Mukh Mantri Sehat Yojna is helping patients, including senior ...

In theory, hypertension is a disease that is both easy to test for and readily treatable with existing medications and ...

Peppermint oil may help reduce blood pressure in adults with mild hypertension with early findings suggesting a natural and ...

Have you been diagnosed with hypertension, or dealing with fluctuating blood pressure? Read on to know the real facts about ...